all AI news
Gen AI and quantum to design new drugs: Paris-based Aqemia completes €60m Series A
Jan. 30, 2024, 5 a.m. | Daphné Leprince-Ringuet
Latest from Sifted sifted.eu
The French biotech combines generative AI with quantum-inspired algorithms to “invent” new molecules that can target certain diseases
Gen AI and quantum to design new drugs: Paris-based Aqemia completes €60m Series A
ai and quantum algorithms biotech deals design diseases drugs french gen gen ai generative molecules paris quantum series series a
More from sifted.eu / Latest from Sifted
AI could save lives in the NHS – but a lack of adoption pathways are …
1 week, 1 day ago |
sifted.eu
I’m an ex-founder — here’s how I’d build my company again with GenAI
1 week, 1 day ago |
sifted.eu
Jobs in AI, ML, Big Data
Data Architect
@ University of Texas at Austin | Austin, TX
Data ETL Engineer
@ University of Texas at Austin | Austin, TX
Lead GNSS Data Scientist
@ Lurra Systems | Melbourne
Senior Machine Learning Engineer (MLOps)
@ Promaton | Remote, Europe
Risk Management - Machine Learning and Model Delivery Services, Product Associate - Senior Associate-
@ JPMorgan Chase & Co. | Wilmington, DE, United States
Senior ML Engineer (Speech/ASR)
@ ObserveAI | Bengaluru